Skip to main content

People

Yingda (Linda) Xie, MD – Public Health Research, Division of Infectious Diseases, Department of Medicine

Assistant Professor

Dr. Y. (Linda) Xie and her research team conducts clinical and translational studies in tuberculosis (TB) diagnostics, biomarkers, and AI-interpreted clinical imaging. Their interests include detecting and treating TB at

Chaoyang Xue, PhD – Public Health Research Institute; Department of Microbiology, Biochemistry and Molecular Genetics

Associate Professor

Fungal diseases are serious threats to human health with very limited treatment options. The Xue lab studies the human pathogen Cryptococcus neoformans, the leading cause of life-threatening fungal meningitis. We

Jason Yang, PhD – Center for Emerging and Re-Emerging Pathogens; Department of Biochemistry and Molecular Genetics

Assistant Professor and Chancellor Scholar

The Yang Lab seeks to develop next-generation therapies for chronic and infectious diseases using innovative systems and synthetic biology approaches. Research in the lab bring together high-throughput experimentation, predictive network

George Yap, PhD – Center for Immunity & Inflammation; Department of Medicine

Professor

Research in the Yap laboratory is centered on elucidating fundamental mechanisms of host resistance and disease tolerance required for survival during infection. The laboratory primarily uses mouse models of Toxoplasma

Shobha Swaminathan, MD – Department of Medicine, Division of Infectious Diseases, Rutgers Health New Jersey Medical School

Associate Professor

Dr. Swaminathan is an Associate Professor of Medicine at Rutgers New Jersey Medical School. She is the Clinical Research Site Leader for the NIH funded Clinical Trials Unit At Rutgers

Reynold A. Pannettieri, Jr., MD – Rutgers Institute for Translational Medicine and Science

Vice Chancellor and Director for Translational Medicine and Science, Emeritus Professor of Medicine

Reynold A. Panettieri, Jr, MD, the inaugural Director of the Institute for Translational Medicine and Science and Vice Chancellor for Translational Medicine and Science at Rutgers University, previously served as the Director

Martin J. Blaser, MD – Director of the Center for Advanced Biotechnology and Medicine

Henry Rutgers Chair of the Human Microbiome, Professor, Departments of Medicine and Pathology & Laboratory Medicine RBHS, Robert Wood Johnson Medical School

My lab has been studying gastrointestinal biology since 1979, gastric colonization since 1986, GI tract cancers since 1990, and the human microbiome since 2002. We conducted studies linking H. pylori

Priyadarshini (Priya) Kachroo, PhD – Department of Biomedical and Health Informatics, School of Health Professions; Center for Immunity & Inflammation

Assistant Professor

Dr. Priyadarshini Kachroo received her Ph.D. in Natural Sciences at the University of Kiel, Germany (2016). As a postdoctoral fellow and Instructor at the Brigham and Women’s Hospital and Harvard

Bobby Brooke Herrera, PhD – Assistant Professor of Global Health, Rutgers Global Health Institute

Assistant Professor, Department of Medicine - Division of Allergy, Immunology, and Infectious Diseases; Resident Scientist, Child Health Institute of New Jersey, Robert Wood Johnson Medical School

Bobby Brooke Herrera is an Assistant Professor of Global Health at Rutgers Global Health Institute.  He holds joint appointments in the Division of Allergy, Immunology, and Infectious Diseases in the Department of

Tricia Burdo, PhD – Department of Medicine, Division of Allergy, Immunology and Infectious Diseases and Rutgers Institute for Translational Medicine & Science

Henry Rutgers Endowed Professor of Translational Medicine & Science, Rutgers Biomedical and Health Sciences; Professor of Medicine, Robert Wood Johnson Medical School; Associate Director, Rutgers Institute for Translational Medicine & Science (RITMS); Director of Training, RITMS

Dr. Burdo’s research interests are centered around human immunodeficiency virus (HIV)-associated co-morbidities, HIV-associated chronic inflammation, and HIV cure. This work involves three main foci 1. HIV-associated cardiovascular disease and cardiac